Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

TCT 2021 | Impact of COVID-19 on HSCT and cellular therapies in the US

Katie Maurer • 2 Feb 2021
TCT 2021
General

Katie Maurer, MD, PhD, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, discusses the impact of the COVID-19 pandemic on hematopoietic stem cell transplantation (HSCT) and immune effector cell therapies at the Dana-Farber Cancer Insitute. In this analysis, Dr Maurer reports that with appropriate safety precautions and screening procedures, HSCT and immune effector cell therapies can be safely administered through the ongoing COVID-19 pandemic. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

More from Katie Maurer

Advances in GvHD and maintenance following transplant
0:49
Advances in GvHD and maintenance following transplant
Katie Maurer • 5 Feb 2021
Learnings of COVID-19 on transplant and cellular therapies
1:38
Learnings of COVID-19 on transplant and cellular therapies
Katie Maurer • 5 Feb 2021

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals